Small cell lung cancer: Results of a pha
β
David Cunningham; S. W. Banham; M. Soukop
π
Article
π
1986
π
Springer
π
English
β 220 KB
Fourteen patients with small cell lung cancer (SCLC) received treatment with 1,2,4 triglycidylurazol (TGU) 600 mg/m2 or 800 mg/m2 as an IV bolus every 4 weeks. Twelve patients had received previous chemotherapy consisting of a five-drug regimen given for the short duration of only 9 weeks. All had m